BMY vs IQST · P/E 17, rev $24.46B vs rev $207.0M
Bristol-Myers Squibb Company (BMY) versus Iqstel Inc (IQST) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
Iqstel Inc (IQST) is a telecom services company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported IQST revenue for 2026-06-30 was $207.0M. Net income was -$3.8M. IQST currently screens at market cap $6.5M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. IQST currently screens at market cap $6.5M.
Not investment advice. Open the BMY and IQST stock pages for the full models.
Not investment advice.